Drugs / GSK2838500A
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01678677 | Aug 2012 → Jan 2014 | respiratory system disorder | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT01657526 | Aug 2012 → Nov 2013 | respiratory system disorder | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK2838500A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01657526 ↗ |
| Modality | Vaccine | “Investigational Vaccine” NCT01678677 ↗ |
| Route | Intramuscular | “Intramuscular vaccination in the deltoid region of the non-dominant arm according to protocol schedule.” NCT01678677 ↗ |